Profound Medical Corp. held its 2026 Annual Meeting on May 13, 2026, electing eight directors, ratifying auditors, and approving unallocated RSUs/DSUs under the long-term incentive plan.
Key takeaways
All eight director nominees were elected with majority support, ranging from 78.999% to 91.495%.
PricewaterhouseCoopers LLP was ratified as auditor with 99.497% of votes cast.
Shareholders approved unallocated RSUs/DSUs under the long-term incentive plan with 63.922% for and 36.078% against.
The meeting was held on May 13, 2026, and results were filed on May 15, 2026.